These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25880572)

  • 1. Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation.
    Chang IC; Chen LY; Chong JP; Austin E; Quay CN; Gong L; Mark Richards A; Ling LH
    Int J Cardiol; 2015 Jun; 188():10-2. PubMed ID: 25880572
    [No Abstract]   [Full Text] [Related]  

  • 2. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.
    Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA
    J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
    Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
    Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients.
    Fonseca AC; Brito D; Pinho e Melo T; Geraldes R; Canhão P; Caplan LR; Ferro JM
    Int J Stroke; 2014 Jun; 9(4):419-25. PubMed ID: 23981586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
    Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
    Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-regional pro-adrenomedullin and N-terminal pro B-type natriuretic peptide predict the recurrence of atrial fibrillation after cryoballoon pulmonary vein isolation.
    Elmas E; Tülümen E; Liebe V; Rudic B; Lang S; Akin İ; Schimpf R; Borggrefe M
    Int J Cardiol; 2016 Jan; 203():369-71. PubMed ID: 26539959
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion.
    Wozakowska-Kaplon B
    Int J Cardiol; 2010 Oct; 144(3):436-7. PubMed ID: 19556018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
    Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
    Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy.
    Matsuura H; Murakami T; Hina K; Yamamoto K; Kawamura H; Sogo T; Shinohata R; Usui S; Ninomiya Y; Kusachi S
    Clin Biochem; 2008 Feb; 41(3):134-9. PubMed ID: 18039472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation].
    Kurpesa M
    Kardiol Pol; 2009 Mar; 67(3):262-4. PubMed ID: 19469063
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions.
    Hakala T; Hedman A; Turpeinen A; Kettunen R; Vuolteenaho O; Hippeläinen M
    Eur J Cardiothorac Surg; 2002 Dec; 22(6):939-43. PubMed ID: 12467817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: discordant ANP and B-type natriuretic peptide response to exercise testing.
    Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1203-9. PubMed ID: 20487352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
    Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
    Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide concentration in pericardial fluid is independently associated with atrial fibrillation after off-pump coronary artery bypass surgery.
    Nakamura T; Azuma A; Sawada T; Sakamoto K; Yamano T; Yaku H; Matsubara H
    Coron Artery Dis; 2007 Jun; 18(4):253-8. PubMed ID: 17496488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis.
    Liu Y; Xiao Y; Chen X; Zhang F
    Chin Med J (Engl); 2014; 127(15):2824-8. PubMed ID: 25146622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Biomarkers in Atrial Fibrillation.
    Chang KW; Hsu JC; Toomu A; Fox S; Maisel AS
    Am J Med; 2017 Dec; 130(12):1351-1357. PubMed ID: 28822701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.